Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Ossium Health Snares $63M Series B

2021-03-22
SAN FRANCISCO, CA, Ossium Health announced the completion of its $63 million Series B funding round co-led by General Catalyst and Vivo Capital.
Ossium Health, a therapeutics company harnessing stem cell science to improve treatment for patients with blood and immune diseases, announced the completion of its $63 million Series B funding round co-led by General Catalyst and Vivo Capital with participation from previous investors First Round Capital, Manta Ray Ventures, and XYZ Capital.

Ossium Health is a therapeutics company that leverages its unique deceased donor bone marrow banking platform to develop stem cell therapies for patients with life-threatening blood and immune diseases.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors